Public Joint-Stock Company "Human Stem Cells Institute" announced a private placement of 12,500,000 common shares of par value RUB 0.1 per share on August 19, 2021. The issue price will be determined by the company's board of directors. The transaction will include participation from returning investor PJSC International Medical Center Processings and Kriokhraneniya of Biomaterialy.

Bank of Russia has registered the additional issue of common shares of the company under the state registration number 1-01-08902-?-004D.